Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annalisa Maddalena Scopinaro
Observed names:
Annalisa M. Scopinaro,
Annalisa Scopinaro
ORCID:
0009-0007-9954-3599
Observed ORCID:
0009-0007-9954-3599
OpenAlex ID:
A5019728911
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators
2025
·
Emma Diletta Stea
, Mariateresa Pugliano
, et al.
·
Pharmacological Research
·
13
Diagnostic-therapeutic pathway and organizational model for gene therapy in the administration of congenital retinal dystrophies in real-life
2023
·
Francesco Bandello
, Maurizio Battaglia Parodi
, et al.
·
AboutOpen
·
1
PDF
The patient’s perspective in the pharmaceutical regulatory and access pathway: considerations and recommendations from the 2025 Patient Forum
2026
·
Claudio Jommi
, Fabio Amanti
, et al.
·
Global & Regional Health Technology Assessment
PDF
Generalized Pustular Psoriasis: A Cost-of-Illness and Health-Related Quality of Life Study in Italy
2026
·
Ludovica Borsoi
, Patrizio Armeni
, et al.
·
PharmacoEconomics - Open
PDF
Blended adapted sailing therapy with telerehabilitation for rare skeletal disorders: protocol for a pilot randomised controlled feasibility trial in Italy (PaS2-EXTEND)
2026
·
Manila Boarini
, Federico Banchelli
, et al.
·
BMJ Open
Show more works
View as search
Works count:
5
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type